Learn About Prostate Cancer Treatment Options
Understanding Prostate Cancer Basics The prostate is a small gland that is part of the male reproductive system. It sits below the bladder and in front of th...
Understanding Prostate Cancer Basics
The prostate is a small gland that is part of the male reproductive system. It sits below the bladder and in front of the rectum. The prostate makes fluid that protects and nourishes sperm. Prostate cancer occurs when malignant cells form in the prostate gland tissue.
According to the American Cancer Society, prostate cancer is the most common cancer among men in the United States, aside from skin cancer. In 2024, an estimated 299,010 new cases of prostate cancer will be diagnosed, and approximately 34,800 men will die from the disease. However, most men diagnosed with prostate cancer do not die from it. Many live for years or decades after diagnosis, especially when the cancer is caught early.
Prostate cancer develops slowly in many cases. Some men have aggressive forms that grow quickly, while others have slow-growing tumors that may never cause serious problems. This variation is one reason why treatment decisions differ so much from person to person. A man diagnosed with prostate cancer at age 50 might have a very different treatment path than a man diagnosed at age 75.
Risk factors for prostate cancer include age (risk increases after age 50), family history, race (African American men have higher rates), and certain genetic mutations. Men with a family history of prostate cancer should discuss screening with their doctor starting in their 40s. Men without risk factors may begin conversations about screening around age 50.
Practical Takeaway: Learning the difference between slow-growing and aggressive prostate cancer helps explain why different men receive different treatment recommendations. Not all prostate cancers require immediate or aggressive treatment.
Active Surveillance and Watchful Waiting
Active surveillance and watchful waiting are two approaches used when men are diagnosed with low-risk or early-stage prostate cancer. While these terms are sometimes used interchangeably, they have important differences. Both involve monitoring the cancer rather than treating it immediately.
Active surveillance is typically used for men with low-risk prostate cancer who are expected to live more than 20 years. With this approach, doctors closely monitor the cancer through regular PSA blood tests (usually every 3 to 6 months), digital rectal exams, and periodic biopsies (usually every 1 to 3 years). Men on active surveillance are watched carefully, and treatment begins if tests show the cancer is growing or changing. Studies show that many men on active surveillance never need treatment during their lifetime.
Watchful waiting is similar but involves less frequent monitoring. It is often used for older men (typically over 70) or those with other serious health conditions that limit life expectancy. With watchful waiting, doctors monitor PSA levels and symptoms, but biopsies may not be repeated. Treatment is typically started only if the man develops symptoms like urinary problems or pain.
The rationale behind these approaches is straightforward: many prostate cancers grow so slowly that they never threaten a man's life or quality of life. The side effects of surgery or radiation—such as incontinence, erectile dysfunction, and bowel problems—may cause more harm than the untreated cancer itself. By monitoring rather than treating immediately, men avoid these potential complications unless the cancer shows signs of becoming dangerous.
A landmark study published in the New England Journal of Medicine followed men with low-risk prostate cancer for over a decade. Results showed that men on active surveillance had similar survival rates to men who received immediate treatment, but fewer experienced side effects from treatment.
Practical Takeaway: Active surveillance and watchful waiting are legitimate treatment options for many men with low-risk prostate cancer, allowing them to avoid treatment side effects while still being monitored closely.
Radiation Therapy Options
Radiation therapy uses high-energy beams to kill cancer cells. For prostate cancer, radiation may be used as a primary treatment (instead of surgery) or combined with other treatments. Two main types of radiation are used for prostate cancer: external beam radiation therapy (EBRT) and brachytherapy (internal radiation).
External beam radiation therapy (EBRT) delivers radiation from a machine outside the body, similar to getting an X-ray. The radiation is directed at the prostate from multiple angles to maximize damage to cancer cells while limiting exposure to surrounding tissue. Modern EBRT techniques include intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), which allow doctors to shape and aim the radiation beam more precisely. Treatment typically occurs 5 days a week for 6 to 9 weeks, with each session lasting 15 to 30 minutes.
Brachytherapy, or seed implantation, involves placing small radioactive seeds directly into the prostate gland. This can be done as a permanent implant (where seeds remain in place and gradually lose radioactivity over months) or temporary implant (where seeds are removed after treatment). Brachytherapy delivers radiation directly to cancer cells while reducing radiation exposure to surrounding tissues. Treatment can often be completed in one or a few procedures, making it less time-intensive than EBRT.
Radiation therapy is often combined with hormone therapy (also called androgen deprivation therapy or ADT) for men with intermediate or high-risk cancer. The hormone therapy shrinks the cancer before radiation and may continue during and after radiation treatment. Studies show this combination improves outcomes for men with higher-risk disease.
Common side effects of radiation include urinary symptoms (frequency, urgency, burning), bowel symptoms (diarrhea, rectal irritation), and erectile dysfunction. Most side effects improve within weeks or months after treatment ends, though some may persist long-term. Modern radiation techniques have reduced rates of serious side effects compared to older methods.
Practical Takeaway: Radiation therapy is a non-surgical option that can be as effective as surgery for many men, with different forms available depending on cancer stage and individual circumstances.
Surgical Treatment: Prostatectomy
Radical prostatectomy is surgery to remove the entire prostate gland, the seminal vesicles, and nearby lymph nodes. It is one of the most common treatments for localized prostate cancer (cancer contained within the prostate). The goal is to remove all cancer cells while preserving surrounding tissues and structures that affect quality of life, particularly the nerves that control erections.
Three main surgical approaches are used: open surgery (retropubic or perineal prostatectomy), laparoscopic surgery (minimally invasive using small incisions and a camera), and robotic-assisted laparoscopic surgery (using a robot to control surgical instruments). Robotic-assisted surgery has become increasingly common because it offers surgeons a magnified view and greater precision, potentially reducing complications and recovery time.
Open surgery involves a larger incision in the abdomen or between the scrotum and anus. While more invasive, it allows the surgeon to feel tissues directly and may be preferred in certain situations. Laparoscopic and robotic approaches use several small incisions (typically 5 to 6), through which a camera and instruments are inserted. These minimally invasive approaches generally result in less blood loss, shorter hospital stays, and faster recovery compared to open surgery—often 1 to 2 weeks instead of 3 to 4 weeks.
The surgeon faces a critical challenge during prostatectomy: balancing complete cancer removal with preservation of the nerves that control erections. In "nerve-sparing" prostatectomy, the surgeon carefully preserves these nerves on one or both sides of the prostate if the cancer location allows it. However, if the cancer is close to these nerves, the surgeon may need to remove them to ensure all cancer is removed, increasing the risk of erectile dysfunction afterward.
Common side effects after prostatectomy include temporary urinary incontinence (leaking urine), erectile dysfunction, and pain or discomfort at the incision site. Most men regain urinary control within weeks to months, though some experience long-term incontinence. Erectile dysfunction may occur immediately or develop gradually over months. Men should discuss nerve-sparing options and realistic expectations about side effects with their surgeon before the procedure.
Practical Takeaway: Prostatectomy offers the advantage of removing the cancer completely in one procedure, but involves recovery time and potential side effects that men should carefully consider alongside benefits.
Hormone Therapy and Systemic Treatments
pRelated Guides
More guides on the way
Browse our full collection of free guides on topics that matter.
Browse All Guides →